| Protocol No. | Title | Status |
| 05-0106-10 | Classification of Acute Lymphoblastic Leukemia | Open |
| 05-0142-04 | High Risk B-Precursor Acute Lymphoblastic Leukemia | Open |
| 05-0226-04 | Arizona Lymphoid Tissue and Blood Repository (ALTBR) | Open |
| 08-0386-01 | Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) | Open |
| 08-1071-04 | A Phase II, Open-Label Study of Bortezomib (Velcade), Cladribine and Rituximab (VCR) in Advanced, Newly Diagnosed and Relapsed/Refractory Mantle Cell and Indolent Lymphomas (Protocol UACC/UMass) | Open |
| 09-0679-04 | A Phase II Study Of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) For Treatment Of Hematologic Malignancies And Hematopoietic Failure States | Open |
| 09-0822-10 | COG AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies | Open |
| 09-0967-04 | Lymphoma Outcomes and Epidemiological Database | Open |
| 10-0383-10 | Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib: IND # 73969, NSC # 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL) | Open |
| 10-0637-10 | COG AALL08B1: Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) | Open |
| 12-0176-04 | SWOG 0805 "Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) with or without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) (a BMT Study)" | Open |
| 2002-0063 | PROTOCOL FOR A RESEARCH DATABASE FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION AND MARROW TOXIC INJURIES | Open |
| 20110931 | Phase 1b, Escalating Dose Study of AVL-292, a Bruton’s Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects with Relapsed and/or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom’s Macroglobulinemia | Open |
| COGAALL0932 | COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL) | Open |
| NMDP2011-0264 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications, version 3.0 | Open |